Header widget area left
Header widget area right

Inform Bioscience, a subsidiary of Metabolomic Diagnostics, is a Personalized Molecular Diagnostics company focused on commercialising novel biomarkers for early detection of life threatening conditions resulting in better interventions through informed clinical opinion.

The company recently licensed novel technology from the Mayo Clinic which through a non-invasive urine test can detect if a woman has pre-eclampsia early in her pregnancy.

Inform Bioscience is supported by a team of entrepreneurs, investors, scientists and clinicians focused on delivering novel medical solutions to support a personalised medicine approach.

Meet The Team


Charles Garvey


Charles Garvey is the CEO of Inform Bio and its parent company Metabolomic Diagnostics Ltd. Charles is a serial entrepreneur with extensive experience in growing Irish technology companies internationally. He was formerly CEO of Horizon Technology Group Plc which he grew into a major European company, listed in the London & Dublin stock exchanges and eventually sold to Avnet in 2007.

He has extensive experience in M&A, in forging and managing partnerships with major multinational companies and in corporate finance and fundraising through angel investors, VCs, banks and public markets.


Paul Hands

Commercial Director

Paul Hands is the Commercial Director of Inform Bio and a successful business graduate and serial entrepreneur with more than 30 years experience in the technology and life science business sectors. He is recognized for an outstanding mix of strategic vision, global management skills and the proven ability to scale a business across several continents. He has successfully completed multiple venture funding rounds and has established an international network of professional associates.


Dr. Christine Loscher

Dr. Loscher is Director of Dublin City University’s new Health Technologies Research and Enterprise Hub and will be working with InformBio under an Innovation Partnership funded by Enterprise Ireland.

She has significant expertise in the fields of Cellular Immunology and Immunomodulation and her team has extensive experience in flow cytometry development.


Diarmuid Cahalane

Diarmuid Cahalane is Compliance and Regulatory Director of InformBio. He has been consulting to the technology and life sciences sectors for over 20 years. He is recognised for his strengths in risk analysis, remediation, cost reduction and compliance. In 1997, he established his own regulatory consulting company, and went on to work with many of the leading global life science companies, including Pfizer, Schering Plough, and Glaxo Smithkline providing advice projects.


Prof. Richard O' Kennedy

Prof. Richard O’Kennedy is Professor of Biological Sciences at DCU and Deputy Director of the Biomedical Diagnostics Institute in DCU and will be working with InformBio under an Innovation Partnership funded by Enterprise Ireland.

He has significant expertise in immunoassays, antibody generation and his team has extensive experience in ELISA development


Robin Tuytten

Robin Tuytten serves as Vice President Research and Development of InformBio and its parent company Metabolomic Diagnostics Ltd. Robin has a PhD in Chemistry and has been involved in biomarker discovery and development for nearly a decade. Robin has been leading preeclampsia biomarker discovery programs in several start-up companies, and is a co-inventor on several preeclampsia protein biomarker patent applications.